image
Aptevo Therapeutics Inc. APVO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.211
-12.4 %
$ 3.91 M
Market Cap
-0.02
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-28.9 M OPERATING INCOME
-0.83%
Growth Rates
1Year -0.83%
3Years -1.65%
5Years 10.98%
7Years 19.07%
10Years 5.95%
-17.4 M NET INCOME
-216.91%
Growth Rates
1Year -216.91%
3Years 0.64%
5Years 20.17%
7Years 23.39%
10Years 10.59%
EFFICIENCY
Earnings Waterfall Aptevo Therapeutics Inc.
image
Revenue 0
Cost Of Revenue 567 K
Gross Profit -567 K
Operating Expenses 28.9 M
Operating Income -28.9 M
Other Expenses -11.5 M
Net Income -17.4 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 0 3.1 12.3 4.3 32.4 23.1 14.7 36.4 33.6 45.6 0.2
GROSS PROFIT
Cost Of Revenue 0.6 0.9 19.0 17.9 19.9 11.2 5.0 24.2 16.9 16.3 38.1
Gross Profit (0.6) 2.2 (6.7) (13.5) 12.5 11.9 9.6 12.3 16.7 29.4 (37.9)
OPERATING INCOME
Operating Expenses 28.9 31.8 33.7 31.8 41.0 63.5 63.6 68.2 77.8 80.9 53.5
Selling, General and Administrative Expenses 11.8 13.9 14.7 14.0 16.2 28.1 34.6 38.7 43.0 34.3 15.5
Research and Development Expenses 16.5 17.9 19.0 17.9 24.8 35.4 29.0 29.5 34.7 46.6 38.1
Operating Income (28.9) (28.6) (21.4) (27.5) (41.0) (51.7) (53.9) (126.9) (61.1) (51.5) (53.4)
PRE-TAX INCOME
Interest Income Expense 0 (35.7) 0 0 0 0 0 0 0 0 0
Total Other Income 10.2 35.7 (8.0) (3.4) (2.1) (2.0) (1.9) (12.6) (0.2) (0.2) 18 K
Pre-Tax Income (18.6) 7.0 (29.4) (30.9) (43.1) (53.7) (55.9) (127.8) (61.3) (51.7) (53.3)
NET INCOME
Tax Provision 0 (35.7) (2.1) (12.5) (2.6) (2.0) (23.3) (15.3) (2.0) (0.6) 18 K
Net Income (17.4) 42.7 (27.3) (18.4) (40.4) (53.7) 7.0 (112.4) (59.3) (51.1) (53.3)
EPS 72 367 256 239 610 1.47 K 941 3.42 K 1.81 K 1.56 K 1.62 K